Skip to main content
Clinical Trials/DRKS00016330
DRKS00016330
Completed
Phase 3

Multicentre, randomized controlled trial of the Frankfurt Early Intervention Program for tod-dlers and preschool children with Autism Spectrum Disorder – A-FFIP - A-FFIP

Goethe Universität Frankfurt am Main0 sites134 target enrollmentJanuary 4, 2019

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
DSM-5: 299.0 Autism Spectrum Disorder
Sponsor
Goethe Universität Frankfurt am Main
Enrollment
134
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 4, 2019
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Autism Spectrum Disorder according to DSM\-5

Exclusion Criteria

  • Key exclusion criteria: non\-verbal IQ/DQ \<\= 30, non\-verbal mental age \< \=12 months, sensory impairments, cerebral palsy, chronic neurological disorder, unstable epilepsy, neurodegenerative disorder, Rett / Angelman Syndrome, severe psychosocial deprivation, insufficient care by parents, attachment disorder, institutional upbringing, parents not verbally fluent in German and/or unable to read German. Amendment from October 16, 2018: A correction of the key exclusion criteria from non\-verbal IQ/DQ \<40, non\-verbal mental age \< 15 months to non\-verbal IQ/DQ \<\= 30, non\-verbal mental age \< \=12 months was submitted. The ethics commission accepted this on January 24, 2019\.

Outcomes

Primary Outcomes

Not specified

Similar Trials